Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2005 | 12-2004 | |
Sales | 2,230 | 2,436 |
Gross Profit | 2,230 | 2,436 |
Operating Expenses | 35,889 | 19,302 |
Operating Income | -33,659 | -16,866 |
Interest Expense | 358 | 226 |
Other Income | 1,615 | 467 |
Pre-tax Income | -32,402 | -16,625 |
Net Income Continuous | -32,402 | -16,625 |
Net Income | $-32,402 | $-16,625 |
EPS Basic Total Ops | -189.80 | -114.10 |
EPS Basic Continuous Ops | -189.82 | -114.10 |
EPS Diluted Total Ops | -189.80 | -114.10 |
EPS Diluted Continuous Ops | -189.82 | -114.10 |
EBITDA(a) | $-30,682 | $-15,248 |